Clinical Report: Characteristics and Prognostic Indicators of Adrenal Metastases in Differentiated Thyroid Cancer
Overview
This study investigates the clinicopathological characteristics and prognoses of differentiated thyroid cancer (DTC) patients with adrenal metastases (AM) compared to those with other metastatic sites. Findings indicate that DTC patients with AM have poorer survival outcomes and distinct clinical features.
Background
Differentiated thyroid cancer (DTC) is the most common type of thyroid cancer, typically associated with a favorable prognosis. However, the presence of distant metastases, particularly adrenal metastases, significantly worsens survival outcomes. Understanding the characteristics and prognostic indicators of DTC with AM is crucial for optimizing management strategies.
Data Highlights
Characteristic
DTC with AM
Other Metastatic Sites
RAIR-DTC Proportion
71.43%
44.64%
5-Year OS Rate
65.31%
92.88%
10-Year OS Rate
46.65%
78.23%
Median Follow-Up (months)
29.6
69.3
Key Findings
The DTC-AM group had a significantly higher rate of RAIR-DTC compared to the non-DTC-AM group.
35.71% of patients in the DTC-AM group died during follow-up, compared to 14.29% in the non-DTC-AM group.
Advanced age at diagnosis (≥60 years) was associated with poorer survival outcomes in DTC patients with AM.
Large primary tumor size (≥4 cm) was identified as an independent risk factor for unfavorable prognosis.
Patients with DTC-AM often present with multiple synchronous distant metastatic sites.
Clinical Implications
Clinicians should be aware that the presence of adrenal metastases in DTC patients correlates with a poorer prognosis and may necessitate more aggressive treatment strategies. Early identification and management of RAIR-DTC are critical for improving patient outcomes.
Conclusion
Adrenal metastases in differentiated thyroid cancer significantly impact survival and are associated with distinct clinical characteristics. Further research is needed to develop standardized management protocols for these patients.
